Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Wagner

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of Electrocardiology|November 28, 2016
In memory of Professor Galen S. Wagner M.D., Ph.D. (1939-2016): our mentor, colleague and friendMarilyn Wagner, Laura Wagner, Chris Wagner, et al.
The Lancet. Infectious Diseases|April 28, 2025
Immunogenicity and safety of different immunisation schedules of the VLA15 Lyme borreliosis vaccine candidate in adults, adolescents, and children: a randomised, observer-blind, placebo-controlled, phase 2 trialLaura Wagner, Michaela Obersriebnig, Vera Kadlecek, et al.
The Lancet. Infectious Diseases|July 19, 2024
Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trialSanthosh Kumar Ghadge, Martina Schneider, Katrin Dubischar, et al.
The Lancet. Infectious Diseases|November 10, 2025
Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in children, adolescents, and adults in the USA: a randomised, observer-blind, placebo-controlled, phase 2 trialLaura Wagner, Michaela Obersriebnig, Romana Hochreiter, et al.
Journal of Pain and Symptom Management|May 4, 2019
Deleterious Effects of Higher Body Mass Index on Subjective and Objective Measures of Chemotherapy-Induced Peripheral Neuropathy in Cancer SurvivorsIva Petrovchich, Kord M Kober, Laura Wagner, et al.
Infection|September 9, 2024
Evaluation of a host-protein signature score for differentiating between bacterial and viral infections: real-life evidence from a German tertiary hospitalLaura Wagner, Heike Schneider, Peter B Luppa, et al.
Aging and Disease|May 18, 2023
Huntingtin Decreases Susceptibility to a Spontaneous Seizure Disorder in FVN/B MiceJeremy M Van Raamsdonk, Hilal H Al-Shekaili, Laura Wagner, et al.
Microbiology Spectrum|June 5, 2025
Risk factors for vancomycin resistance in patients with <i>Enterococcus faecium</i> bloodstream infections: an analysis of the Munich Multicentric Enterococci CohortLaura Wagner, Milena Wurst, Johanna Erber, et al.
Infection|June 17, 2025
The impact of age, sex, and comorbidities on COVID-19 mortality of hospitalized patients during the SARS-CoV-2 pandemic: data from the multicentric prospective cohort study of the Lean European Open Survey on SARS-CoV-2 (LEOSS)Julian Triebelhorn, Maria M Rüthrich, Susana M Nunes de Miranda, et al.
Journal of Gastroenterology and Hepatology|June 5, 2024
LINAS-Score: prognostic model for mortality assessment in patients with cirrhotic liver and infected ascitesSilvia Würstle, Tillman Schneider, Siranush Karapetyan, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Electrocardiology|November 28, 2016
In memory of Professor Galen S. Wagner M.D., Ph.D. (1939-2016): our mentor, colleague and friendMarilyn Wagner, Laura Wagner, Chris Wagner, et al.
The Lancet. Infectious Diseases|April 28, 2025
Immunogenicity and safety of different immunisation schedules of the VLA15 Lyme borreliosis vaccine candidate in adults, adolescents, and children: a randomised, observer-blind, placebo-controlled, phase 2 trialLaura Wagner, Michaela Obersriebnig, Vera Kadlecek, et al.
The Lancet. Infectious Diseases|July 19, 2024
Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trialSanthosh Kumar Ghadge, Martina Schneider, Katrin Dubischar, et al.
The Lancet. Infectious Diseases|November 10, 2025
Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in children, adolescents, and adults in the USA: a randomised, observer-blind, placebo-controlled, phase 2 trialLaura Wagner, Michaela Obersriebnig, Romana Hochreiter, et al.
Journal of Pain and Symptom Management|May 4, 2019
Deleterious Effects of Higher Body Mass Index on Subjective and Objective Measures of Chemotherapy-Induced Peripheral Neuropathy in Cancer SurvivorsIva Petrovchich, Kord M Kober, Laura Wagner, et al.
Infection|September 9, 2024
Evaluation of a host-protein signature score for differentiating between bacterial and viral infections: real-life evidence from a German tertiary hospitalLaura Wagner, Heike Schneider, Peter B Luppa, et al.
Aging and Disease|May 18, 2023
Huntingtin Decreases Susceptibility to a Spontaneous Seizure Disorder in FVN/B MiceJeremy M Van Raamsdonk, Hilal H Al-Shekaili, Laura Wagner, et al.
Microbiology Spectrum|June 5, 2025
Risk factors for vancomycin resistance in patients with <i>Enterococcus faecium</i> bloodstream infections: an analysis of the Munich Multicentric Enterococci CohortLaura Wagner, Milena Wurst, Johanna Erber, et al.
Infection|June 17, 2025
The impact of age, sex, and comorbidities on COVID-19 mortality of hospitalized patients during the SARS-CoV-2 pandemic: data from the multicentric prospective cohort study of the Lean European Open Survey on SARS-CoV-2 (LEOSS)Julian Triebelhorn, Maria M Rüthrich, Susana M Nunes de Miranda, et al.
Journal of Gastroenterology and Hepatology|June 5, 2024
LINAS-Score: prognostic model for mortality assessment in patients with cirrhotic liver and infected ascitesSilvia Würstle, Tillman Schneider, Siranush Karapetyan, et al.
Pageof 9